Efficacy and safety of cilta-cel in patients with progressive multiple myeloma after exposure to other BCMA-targeting agents

  1. Cohen, A.D.
  2. Mateos, M.-V.
  3. Cohen, Y.C.
  4. Rodriguez-Otero, P.
  5. Paiva, B.
  6. van de Donk, N.W.C.J.
  7. Martin, T.
  8. Suvannasankha, A.
  9. De Braganca, K.C.
  10. Corsale, C.
  11. Schecter, J.M.
  12. Varsos, H.
  13. Deraedt, W.
  14. Wang, L.
  15. Vogel, M.
  16. Roccia, T.
  17. Xu, X.
  18. Mistry, P.
  19. Zudaire, E.
  20. Akram, M.
  21. Nesheiwat, T.
  22. Pacaud, L.
  23. Avivi, I.
  24. San-Miguel, J.
Revue:
Blood

ISSN: 1528-0020,  0006-4971

Année de publication: 2023

Volumen: 141

Número: 3

Pages: 219-230

Type: Article

DOI: 10.1182/BLOOD.2022015526 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus